$LFVN
Lifevantage Corp Stock $lfvn

$lfvn Overview Financials Valuation SEC Filings Company Website

2018 Q4 Form 10-Q Financial Statement

#000084914619000028 Filed on February 04, 2019

Income Statement

Concept	2018 Q4	2017 Q4	2017 Q2
Revenue	$58.17M	$49.48M	$50.64M
YoY Change	17.55%	1.09%	-4.51%
Cost Of Revenue	$9.794M	$9.117M	$8.890M
YoY Change	7.43%	21.56%	-5.43%
Gross Profit	$48.37M	$40.37M	$41.75M
YoY Change	19.84%	-2.61%	-4.31%
Gross Profit Margin	83.16%	81.58%	82.44%
Selling, General & Admin	$19.62M	$14.64M	$40.21M
YoY Change	33.96%	-14.9%	1.67%
% of Gross Profit	40.55%	36.28%	96.31%
Research & Development	$500.0K	$300.0K
YoY Change	66.67%	0.0%
% of Gross Profit	1.03%	0.74%
Depreciation & Amortization	$440.0K	$320.0K	$420.0K
YoY Change	37.5%	-23.81%	-12.5%
% of Gross Profit	0.91%	0.79%	1.01%
Operating Expenses	$47.79M	$38.04M	$40.21M
YoY Change	25.64%	-6.65%	1.67%
Operating Profit	$581.0K	$2.327M	$1.540M
YoY Change	-75.03%	232.43%	-62.27%
Interest Expense	$100.0K	$103.0K	-$250.0K
YoY Change	-2.91%	-25.36%	-725.0%
% of Operating Profit	17.21%	4.43%	-16.23%
Other Income/Expense, Net	-$172.0K	-$272.0K	-$530.0K
YoY Change	-36.76%	-5.56%	-60.45%
Pretax Income	$409.0K	$2.055M	$760.0K
YoY Change	-80.1%	398.79%	-72.66%
Income Tax	-$420.0K	$1.738M	$680.0K
% Of Pretax Income	-102.69%	84.57%	89.47%
Net Earnings	$829.0K	$317.0K	$84.00K
YoY Change	161.51%	12.01%	-96.55%
Net Earnings / Revenue	1.43%	0.64%	0.17%
Basic Earnings Per Share	$0.06	$0.02	$0.01
Diluted Earnings Per Share	$0.06	$0.02	$0.01
COMMON SHARES
Basic Shares Outstanding	13.94M shares	13.96M shares	14.23M shares
Diluted Shares Outstanding	14.96M shares	14.15M shares

Balance Sheet

Concept	2018 Q4	2017 Q4	2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$18.99M	$12.79M	$11.46M
YoY Change	48.48%	9.04%	45.43%
Cash & Equivalents	$18.99M	$12.79M	$11.46M
Short-Term Investments
Other Short-Term Assets	$6.130M	$4.050M	$5.270M
YoY Change	51.36%	103.52%	-38.43%
Inventory	$13.30M	$16.82M	$16.58M
Prepaid Expenses
Receivables	$2.376M	$1.542M	$1.334M
Other Receivables	$2.860M	$90.00K	$920.0K
Total Short-Term Assets	$43.66M	$35.29M	$35.55M
YoY Change	23.7%	-3.89%	-17.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.848M	$4.644M	$3.127M
YoY Change	25.93%	60.97%	-9.52%
Goodwill
YoY Change
Intangibles	$1.049M	$1.181M	$1.247M
YoY Change	-11.18%	-30.45%	-28.5%
Long-Term Investments
YoY Change
Other Assets	$1.255M	$1.142M	$1.242M
YoY Change	9.89%	-12.49%	-18.29%
Total Long-Term Assets	$10.44M	$10.36M	$9.703M
YoY Change	0.69%	5.81%	25.31%
TOTAL ASSETS
Total Short-Term Assets	$43.66M	$35.29M	$35.55M
Total Long-Term Assets	$10.44M	$10.36M	$9.703M
Total Assets	$54.09M	$45.66M	$45.25M
YoY Change	18.48%	-1.85%	-11.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.108M	$3.269M	$4.850M
YoY Change	25.67%	-35.1%	-45.45%
Accrued Expenses	$22.49M	$17.05M	$16.29M
YoY Change	31.91%	3.33%	-0.97%
Deferred Revenue			$1.743M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.000M	$2.000M	$2.000M
YoY Change	0.0%	0.0%	0.0%
Total Short-Term Liabilities	$28.76M	$22.73M	$23.36M
YoY Change	26.55%	-3.45%	-23.75%
LONG-TERM LIABILITIES
Long-Term Debt	$2.427M	$4.457M	$5.440M
YoY Change	-45.55%	-30.62%	-26.58%
Other Long-Term Liabilities	$1.885M	$1.966M	$1.927M
YoY Change	-4.12%	-3.67%	-11.16%
Total Long-Term Liabilities	$4.312M	$6.423M	$7.367M
YoY Change	-32.87%	-24.12%	-23.08%
TOTAL LIABILITIES
Total Short-Term Liabilities	$28.76M	$22.73M	$23.36M
Total Long-Term Liabilities	$4.312M	$6.423M	$7.367M
Total Liabilities	$33.08M	$29.15M	$30.72M
YoY Change	13.46%	-8.91%	-23.59%
SHAREHOLDERS EQUITY
Retained Earnings	-$102.5M	-$106.1M	-$107.0M
YoY Change	-3.41%	-0.47%	-1.48%
Common Stock	$123.5M	$122.6M	$121.6M
YoY Change	0.7%	1.21%	1.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$21.02M	$16.51M	$14.53M
YoY Change
Total Liabilities & Shareholders Equity	$54.09M	$45.66M	$45.25M
YoY Change	18.48%	-1.85%	-11.02%

Cashflow Statement

Concept	2018 Q4	2017 Q4	2017 Q2
OPERATING ACTIVITIES
Net Income	$829.0K	$317.0K	$84.00K
YoY Change	161.51%	12.01%	-96.55%
Depreciation, Depletion And Amortization	$440.0K	$320.0K	$420.0K
YoY Change	37.5%	-23.81%	-12.5%
Cash From Operating Activities	$4.570M	$2.180M	$1.980M
YoY Change	109.63%	-1.8%	-1337.5%
INVESTING ACTIVITIES
Capital Expenditures	-$180.0K	-$940.0K	-$600.0K
YoY Change	-80.85%	526.67%	900.0%
Acquisitions
YoY Change
Other Investing Activities	-$600.0K
YoY Change
Cash From Investing Activities	-$780.0K	-$940.0K	-$600.0K
YoY Change	-17.02%	526.67%	900.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.990M	-750.0K	880.0K
YoY Change	165.33%	53.06%	-300.0%
NET CHANGE
Cash From Operating Activities	4.570M	2.180M	1.980M
Cash From Investing Activities	-780.0K	-940.0K	-600.0K
Cash From Financing Activities	-1.990M	-750.0K	880.0K
Net Change In Cash	1.800M	490.0K	2.260M
YoY Change	267.35%	-68.99%	-442.42%
FREE CASH FLOW
Cash From Operating Activities	$4.570M	$2.180M	$1.980M
Capital Expenditures	-$180.0K	-$940.0K	-$600.0K
Free Cash Flow	$4.750M	$3.120M	$2.580M
YoY Change	52.24%	31.65%	-2680.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	900000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	21000	USD
	lfvn	Number Of Geographic Segments NumberOfGeographicSegments	2	Segment
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-17000	USD
CY2018Q4	lfvn	Percent Of Restocking Fee PercentOfRestockingFee	0.1
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1336000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	2337000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Document Period End Date DocumentPeriodEndDate	2018-12-31
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000849146
CY2019Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14283765	shares
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	Lifevantage Corp
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Trading Symbol TradingSymbol	LFVN
CY2017Q4	lfvn	Commission And Incentives CommissionAndIncentives	23395000	USD
	lfvn	Commission And Incentives CommissionAndIncentives	46804000	USD
CY2018Q4	lfvn	Commission And Incentives CommissionAndIncentives	28176000	USD
CY2018Q4	lfvn	Revenue Recognition Sale Returns Acceptable Percentage From Terminated Distributors RevenueRecognitionSaleReturnsAcceptablePercentageFromTerminatedDistributors	0.3
CY2017Q4	lfvn	Sharebased Compensation Arrangementby Sharebased Payment Award Increase Decreaseof Sharebased Liabilities SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities	200000	USD
	lfvn	Sharebased Compensation Arrangementby Sharebased Payment Award Increase Decreaseof Sharebased Liabilities SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities	400000	USD
CY2018Q4	lfvn	Sharebased Compensation Arrangementby Sharebased Payment Award Increase Decreaseof Sharebased Liabilities SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities	700000	USD
	lfvn	Sharebased Compensation Arrangementby Sharebased Payment Award Increase Decreaseof Sharebased Liabilities SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities	1400000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-8000	USD
	us-gaap	Interest Paid Net InterestPaidNet	183000	USD
	us-gaap	Interest Paid Net InterestPaidNet	152000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	1903000	USD
	us-gaap	Origination Of Notes Receivable From Related Parties OriginationOfNotesReceivableFromRelatedParties	0	USD
CY2018Q2	lfvn	Stockholders Equity Attributableto Parent Adjusted Balance StockholdersEquityAttributabletoParentAdjustedBalance	21944000	USD
	us-gaap	Origination Of Notes Receivable From Related Parties OriginationOfNotesReceivableFromRelatedParties	2000000	USD
CY2018Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3813000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4108000	USD
CY2018Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2067000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2376000	USD
CY2018Q2	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	7546000	USD
CY2018Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	8071000	USD
CY2018Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	14000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	10000	USD
CY2018Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	124663000	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	123501000	USD
CY2018Q4	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	2974000	USD
CY2017Q4	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	600000	USD
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1000000	USD
CY2018Q4	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1000000	USD
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1600000	USD
CY2018Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	999000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	629000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	10000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	13000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	6000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2000	USD
CY2017Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	300000	shares
CY2018Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000	shares
	lfvn	Commission And Incentives CommissionAndIncentives	55961000	USD
	lfvn	Money Back Guarantee Period MoneyBackGuaranteePeriod	P30D
	lfvn	Noncash Investing And Financing Items Increase In Other Accrued Expenses For Shares Purchased As Paymentof Tax Withholding NoncashInvestingAndFinancingItemsIncreaseInOtherAccruedExpensesForSharesPurchasedAsPaymentofTaxWithholding	0	USD
	lfvn	Noncash Investing And Financing Items Increase In Other Accrued Expenses For Shares Purchased As Paymentof Tax Withholding NoncashInvestingAndFinancingItemsIncreaseInOtherAccruedExpensesForSharesPurchasedAsPaymentofTaxWithholding	2974000	USD
	lfvn	Notes Receivable Related Party Interest Rate NotesReceivableRelatedPartyInterestRate	0.08
CY2018Q4	lfvn	Notes Receivable Related Party Maximum Commitment NotesReceivableRelatedPartyMaximumCommitment	2000000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	200000	shares
CY2018Q2	us-gaap	Assets Assets	51142000	USD
CY2018Q4	us-gaap	Assets Assets	54093000	USD
CY2018Q2	us-gaap	Assets Current AssetsCurrent	38938000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	43658000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11458000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12794000	USD
CY2017Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16652000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18989000	USD
CY2018Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2018Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14073000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14267000	shares
CY2018Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14073000	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14267000	shares
CY2018Q2	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2017Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	363000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1200000	USD
CY2018Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	950000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1736000	USD
CY2018Q2	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	400000	USD
CY2018Q4	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	300000	USD
CY2017Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9117000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	17856000	USD
CY2018Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9794000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	18994000	USD
CY2018Q2	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	-3000	USD
CY2018Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3500000	USD
CY2018Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2500000	USD
CY2018Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	88000	USD
CY2018Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	73000	USD
CY2018Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	4500000	USD
CY2018Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3255000	USD
CY2018Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2283000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	690000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	972000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	672000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	878000	USD
CY2017Q4	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-100000	USD
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-100000	USD
CY2018Q4	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-25000	USD
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-100000	USD
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2018Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2018Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2017Q4	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-100000	USD
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2018Q4	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-100000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-100000	USD
CY2017Q4	us-gaap	Gross Profit GrossProfit	40365000	USD
	us-gaap	Gross Profit GrossProfit	80753000	USD
CY2018Q4	us-gaap	Gross Profit GrossProfit	48373000	USD
	us-gaap	Gross Profit GrossProfit	94782000	USD
CY2017Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2055000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	3313000	USD
CY2018Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	409000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1574000	USD
CY2017Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1738000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2179000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2200000	USD
CY2018Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-420000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-200000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-166000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	471000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1066000	USD
CY2018Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	451000	USD
CY2018Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	2866000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1582000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	308000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	218000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	303000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	192000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	122000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	817000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	420000	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-827000	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	2415000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	215000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-323000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-104000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-7000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-410000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-384000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-1202000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-2206000	USD
CY2017Q4	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	197000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	158000	shares
CY2018Q4	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1019000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1000000	shares
CY2018Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1115000	USD
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1049000	USD
CY2017Q4	us-gaap	Interest Expense InterestExpense	103000	USD
	us-gaap	Interest Expense InterestExpense	265000	USD
CY2018Q4	us-gaap	Interest Expense InterestExpense	100000	USD
	us-gaap	Interest Expense InterestExpense	209000	USD
CY2018Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	10407000	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	14422000	USD
CY2018Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	7859000	USD
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	9364000	USD
CY2018Q2	us-gaap	Inventory Net InventoryNet	13627000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	13301000	USD
CY2018Q2	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	5768000	USD
CY2018Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	3937000	USD
CY2018Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1400000	USD
CY2018Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1400000	USD
CY2018Q2	us-gaap	Liabilities Liabilities	29195000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	33075000	USD
CY2018Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	51142000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	54093000	USD
CY2018Q2	us-gaap	Liabilities Current LiabilitiesCurrent	23805000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	28763000	USD
CY2018Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	2000000	USD
CY2018Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2000000	USD
CY2018Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	1500000	USD
CY2018Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	2000000	USD
CY2018Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	1000000	USD
CY2018Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3412000	USD
CY2018Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2427000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1250000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2316000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2117000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2272000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4682000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6942000	USD
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	317000	USD
	us-gaap	Net Income Loss NetIncomeLoss	1134000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	911000	USD
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	829000	USD
	us-gaap	Net Income Loss NetIncomeLoss	1740000	USD
CY2017Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-272000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-412000	USD
CY2018Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-172000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-329000	USD
CY2018Q4	us-gaap	Notes Receivable Related Parties Current NotesReceivableRelatedPartiesCurrent	2000000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	Segment
CY2017Q4	us-gaap	Operating Expenses OperatingExpenses	38038000	USD
	us-gaap	Operating Expenses OperatingExpenses	77028000	USD
CY2018Q4	us-gaap	Operating Expenses OperatingExpenses	47792000	USD
	us-gaap	Operating Expenses OperatingExpenses	92879000	USD
CY2017Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	2327000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	3725000	USD
CY2018Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	581000	USD
CY2018Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1247000	USD
CY2018Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-102731000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1255000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	46000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	66000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-125000	USD
CY2018Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	121000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-4000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	46000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	66000	USD
CY2018Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	121000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4000	USD
CY2018Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1978000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1885000	USD
CY2017Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-169000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-147000	USD
CY2018Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-72000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-120000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	250000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1500000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2117000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	272000	USD
CY2018Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6141000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6126000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	184000	USD
CY2018Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6587000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5848000	USD
CY2017Q4	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2018Q4	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1000000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1000000	USD
CY2017Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	300000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	500000	USD
CY2018Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	500000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	98609000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-102494000	USD
CY2017Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	49482000	USD
CY2018Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	58167000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	113776000	USD
CY2017Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14643000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	30224000	USD
CY2018Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	19616000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	36918000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1453000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3053000	USD
CY2018Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	172000	USD
CY2018Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12000	USD
CY2017Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	5000000	USD
CY2018Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	2000000	USD
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	100000	shares
CY2018Q4	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1500000	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	21947000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	23531000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	21018000	USD
CY2018Q2	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	39000	USD
CY2018Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	162000	USD
CY2017Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14153000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14117000	shares
CY2018Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14963000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14996000	shares
CY2017Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13956000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13959000	shares
CY2018Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13944000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13996000	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Concentration of Credit Risk</font></div><div style="line-height:120%;padding-bottom:10px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of such risk. Financial instruments with significant credit risk include cash and investments.</font></div></div>
	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Commitments and Contingencies</font></div><div style="line-height:120%;padding-bottom:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contingencies</font></div><div style="line-height:120%;padding-bottom:10px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company accounts for contingent liabilities in accordance with Accounting Standards Codification ("ASC") Topic 450, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contingencies</font><font style="font-family:inherit;font-size:10pt;">. This guidance requires management to assess potential contingent liabilities that may exist as of the date of the financial statements to determine the probability and amount of loss that may have occurred, which inherently involves an exercise of judgment. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. For loss contingencies considered remote, no accrual or disclosures are generally made. Management has assessed potential contingent liabilities as of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;">, and based on the assessment, there are no probable loss contingencies requiring accrual or disclosures within its financial statements.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Legal Accruals</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition to commitments and obligations in the ordinary course of business, from time to time, the Company is subject to various claims, pending and potential legal actions, investigations relating to governmental laws and regulations and other matters arising out of the normal conduct of its business. Management assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in the consolidated financial statements. An estimated loss contingency is accrued in the consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because evaluating legal claims and litigation results are inherently unpredictable and unfavorable results could occur, assessing contingencies is highly subjective and requires judgments about future events. When evaluating contingencies, management may be unable to provide a meaningful estimate due to a number of factors, including the procedural status of the matter in question, the presence of complex or novel legal theories, and/or the ongoing discovery and development of information important to the matters. In addition, damage amounts claimed or asserted against the Company may be unsupported, exaggerated or unrelated to possible outcomes, and as such are not meaningful indicators of a potential liability. Management regularly reviews contingencies to determine the adequacy of financial statement accruals and related disclosures. The amount of ultimate loss may differ from these estimates. It is possible that cash flows or results of operations could be materially affected in any particular period by the unfavorable resolution of one or more of these contingencies. Whether any losses finally determined in any claim, action, investigation or proceeding could reasonably have a material effect on the Company's business, financial condition, results of operations or cash flows will depend on a number of variables, including: the timing and amount of such losses; the structure and type of any remedies; the significance of the impact any such losses, damages or remedies may have on the consolidated financial statements; and the unique facts and circumstances of the particular matter that may give rise to additional factors.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Class Action Lawsuit (</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Smith v. LifeVantage Corp</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">.): </font><font style="font-family:inherit;font-size:10pt;">On January 24, 2018, a purported class action was filed in the United States District Court for the District of Connecticut, entitled </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Smith v. LifeVantage Corp</font><font style="font-family:inherit;font-size:10pt;">., Case No. 3:18-cv-a35 (D. Connecticut filed Jan. 24, 2018). In this action, plaintiff alleged that the Company, its Chief Executive Officer, Chief Sales Officer and Chief Marketing Officer operated a pyramid scheme in violation of a variety of federal and state statutes, including RICO and the Connecticut Unfair Trade Practices Act. On April 16, 2018, the Company filed motions with the court to dismiss the complaint against LifeVantage, dismiss the complaint against the Company's executives, transfer the venue of the case from the State of Connecticut to the State of Utah, and contest class certification. On July 23, 2018, the parties filed a stipulation with the Court agreeing to transfer the case to the Federal District Court for Utah. On September 20, 2018, Plaintiffs filed an amended complaint in Utah. As per the parties stipulated agreement, plaintiff's amended complaint dropped the RICO and Connecticut state law claims and removed the Company's Chief Sales Officer and Chief Marketing Officer as individual defendants (the Chief Executive Officer remains a defendant in the case). However, the amended complaint adds a new antitrust claim, alleging that the Company fraudulently obtained patents for its products and is attempting to use those patents in an anti-competitive manner. LifeVantage filed a Motion to Dismiss the amended complaint on November 5, 2018, Plaintiffs filed a response to LifeVantage’s Motion to Dismiss on December 17, 2018, and LifeVantage filed a reply brief on January 10, 2019. With the matter now being fully briefed for the Court, the Court can issue a ruling based on the briefs submitted by the parties or schedule a hearing for oral argument before entering a decision on the motion. The Company has not established a loss contingency accrual for this lawsuit as it believes liability is not probable or estimable, and the Company plans to vigorously defend against this lawsuit. Nonetheless, an unfavorable resolution of this matter could have a material adverse effect on the Company's business, results of operations or financial condition.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Matters.</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;">In addition to the matters described above, the Company also may become involved in other litigation and regulatory matters incidental to its business and the matters disclosed in this quarterly report on Form 10-Q, including, but not limited to, product liability claims, regulatory actions, employment matters and commercial disputes. The Company intends to defend itself in any such matters and does not currently believe that the outcome of any such matters will have a material adverse effect on the Company's business, financial condition, results of operations and cash flows.</font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:10px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company prepares the condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (GAAP). In preparing these statements, the Company is required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, the Company reviews its estimates, including those related to inventory valuation and obsolescence, sales returns, income taxes and tax valuation reserves, transfer pricing methodology and positions, impairment of receivables, share-based compensation, and loss contingencies.</font></div></div>

Files In Submission

Name	View Source	Status
0000849146-19-000028-index-headers.html	Edgar Link	pending
0000849146-19-000028-index.html	Edgar Link	pending
0000849146-19-000028.txt	Edgar Link	pending
0000849146-19-000028-xbrl.zip	Edgar Link	pending
amended2019espp_ex103.htm	Edgar Link	pending
amendedceoemploymentagreem.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
lfvn-20181231.xml	Edgar Link	completed
lfvn-20181231.xsd	Edgar Link	pending
lfvn-20181231_cal.xml	Edgar Link	unprocessable
lfvn-20181231_def.xml	Edgar Link	unprocessable
lfvn-20181231_lab.xml	Edgar Link	unprocessable
lfvn-20181231_pre.xml	Edgar Link	unprocessable
lfvn_123118x10q.htm	Edgar Link	pending
lfvn_123118xex311.htm	Edgar Link	pending
lfvn_123118xex312.htm	Edgar Link	pending
lfvn_123118xex321.htm	Edgar Link	pending
lfvn_123118xex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LFVN
Lifevantage Corp Stock $lfvn

2018 Q4 Form 10-Q Financial Statement

#000084914619000028 Filed on February 04, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFVN Lifevantage Corp Stock $lfvn

2018 Q4 Form 10-Q Financial Statement

#000084914619000028 Filed on February 04, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFVN
Lifevantage Corp Stock $lfvn